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Detection of Amoebic Meningitis by Wet Film
of Cerebrospinal Fluid (CSF)
Dr Sadia Shakoor,
Resident, Microbiology
Primary Amoebic Meningoencephalitis (PAM) is a
fatal meningitis syndrome caused by the free-living
amoeba Naegleria fowleri. This amoeba is found in
freshwater ponds and lakes. At high temperatures it
may contaminate urban water supplies resulting in
sporadic cases of meningitis. The disease is rare
resembling bacterial meningitis, except for the poor
response to antibacterial therapy. These features lead
to decreased recognition by clinicians and a high
index of suspicion needs to be maintained to
entertain this diagnosis.

The amoebae also exist in flagellar form. CSF
samples can be directly suspended in distilled water
and incubated for 30 minutes to demonstrate rapidly
motile flagellar forms. This may further confirm the
diagnosis. Isolation of amoebae is possible as it can
be cultured on a non-nutrient agar covered with a
lawn of E.coli. Growth can be seen within the next 48
hours.
Treatment regimens with antifungal agents such as
Amphotericin have been suggested, but are largely
ineffective. Prevention of the disease entails
chlorination of water supplies and avoidance of
unchlorinated freshwater activities.

Laboratory diagnosis depends on CSF analysis. This
usually reveals hypoglycorrhachia, high protein
content and high neutrophilic pleocytosis. Amoeba
may easily be missed on
routine cell count on
hemacytometers owing
to the usage of toxic
diluting fluid. When a
diagnosis is suspected, a
simple wet film of the
C S F
w i t h o u t
centrifugation (which
destroys
amoebae)
usually reveals motile
amoebic trophozoites.
Naegleria fowleri moves
sluggishly by means of
rounded lobopodes/
psuedopods (Figure 1).
Cysts are not visible on
CSF films; however,
brain biopsy which is
usually not required can
show cysts as well as
its trophozoites.
Figure 1: Amoebic trophozoites (marked by a black pointer) as visible on a wet preparation of CSF sample.

2

October 2009, Vol. 34, Issue 3

Biochemical Tests in the Diagnosis of Anaemia
Dr Sahar Iqbal,
Resident, Chemical Pathology

Anaemia may be defined as a disorder resulting from
low concentration of haemoglobin or haematocrit in
the blood in relation to age, sex or location. The
combination of haematological and biochemical
studies of blood, enable one to identify underlying
aetiology of anaemia.
Anaemia can be classified morphologically as

microcytic, normocytic and macrocytic depending
on Mean Corpuscular Volume (MCV) of red cells.
The reference ranges for these respectively are
MCV<76, 76-96 and >96 fl for Pakistani population.
The most common differential diagnosis and
biochemical findings of various types of anaemia are
shown in the table1.

Table 1: Differential Diagnosis of Anaemia and Biochemical Findings
Microcytic anaemia

Biochemical test findings

Iron deficiency anaemia

low Serum iron, low ferritin, low SOT, increased
TIBC, FEP increased

Thalassaemic disorders

Ferritin normal or high, SOT high (thalassaemia
major) to normal (thalassaemia trait)

Anaemia of chronic disease (late, uncommon)

Ferritin normal to high, SOT low, iron low, TIBC low,
FEP increased

Sideroblastic anaemia (for example congenital, lead, Iron high, SOT high, ferritin high, TIBC normal, FEP
alcohol, drugs, uncommon)
normal or increased
Copper deficiency, zinc poisoning (rare)

Ferritin normal to high

Normocytic anaemia
Acute blood loss
Iron deficiency anaemia (early)

Described earlier

Anaemia of chronic disease (for example infection,
inflammation, malignancy)

Described earlier

Bone marrow suppression (may also be macrocytic)
Bone marrow infiltration (for example
leukoerythroblastic blood picture)
Acquired pure red blood cell aplasia
Aplastic anaemia
Chronic renal insufficiency

3

Erythropoietin levels decreased, abnormal renal
function tests
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Endocrine dysfunction
Hypothyroidism

TSH increased

Hypopituitarism
Macrocytic anaemia
Folic acid deficiency

Folic acid levels decreased

Vitamin B12 deficiency

Vit B12 levels decreased

Myelodysplastic syndromes
Acute myeloid leukemias (for example
erythroleukemia)
Reticulocytosis
Hemolytic anaemia

Elevated total and indirect bilirubin, SGOT (liver
enzyme) normal, LDH increased, haptoglobin reduced.

Response to blood loss
Drug-induced anaemia (for example Hydroxyurea,
AZT, chemotherapeutic agents)
Liver disease

LFTs abnormal

Ethanol abuse
SOT: saturation of transferrin, TIBC: total iron binding capacity, FEP: free erythrocyte protoporphyrin

Biochemical markers are very helpful to support the
differential diagnoses made by hematological
studies. When taken in conjunction with other
clinical and laboratory features, simple biochemical
tests can be of diagnostic value. Without
hematological information these tests are
nonspecific but they are useful for prompt and
accessible orientation and avoidance of
misdiagnosis of type of anaemia.
Iron deficiency is the most common nutritional
disorder in humans and is also most frequent cause of
anaemia globally. It is estimated that about 3% of
adult men, 20% of women in their reproductive years,
and 50% of pregnant women are deficient in iron.
Iron deficiency develops in stages, the first of which
is the depletion of storage iron in response to a
prolonged negative iron balance. Once iron reserves

are exhausted, biochemical tests of iron metabolism
become abnormal. Next, a drop in hemoglobin
concentration of blood is seen. The diagnostic
usefulness of an isolated serum iron measurement
has limitations as changes up to 20% in serum iron
concentration may occur suddenly, even in the
healthy people, because of momentary imbalances in
iron inflow and outflow. Diurnal variations also
occur as well, so serum iron values should always be
interpreted in combination with TIBC, SOT and
ferritin levels.
In AKUH clinical laboratory serum iron and TIBC
are measured through timed-endpoint
spectrophotometric and serum ferritin through
electrochemical luminescence techniques however
SOT is a calculated measurement.
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Pathophysiology and Laboratory
Investigation in Anaemia of Chronic Disease
Dr Raihan Sajid,
Assistant Professor, Haematology
Anaemia of Chronic Disease (ACD) is the second
most common anaemia after Iron Deficiency
Anaemia (IDA) and is the most frequently observed
anaemia in the hospital setting. It is also known as
anaemia of inflammation, anaemia of chronic
inflammation and hypoferremia of inflammation.
M. Wintrobe used the terminology of 'simple chronic
anaemia' for the normocytic anaemia associated with
infections and chronic systemic diseases in his
famous text book of Clinical Hematology in 1961.
Causes of ACD include acute and chronic infections
which may be viral (including HIV), bacterial,
parasitic, fungal, various types of cancer (both
hematologic and solid) and autoimmune disorders
[like Systemic Lupus Erythromatosis (SLE),
rheumatoid arthritis, vasculitis, sarcoidosis,
inflammatory bowel disease], chronic kidney
disease and chronic rejection subsequent to solid
organ transplants.
Findings in ACD include mild to moderate anaemia
(Hb 8-11 g/dl) while platelet and white cell counts
are usually normal. Mostly the anaemia is
normocytic and normochromic, however, in about
30% of cases it can be hypochromic and microcytic
as well. There may be mild anisocytosis and
poikilocytosis. Reticulocyte count is generally
normal but is inappropriately low for degree of
anaemia. Bilirubin levels are normal and

erythropoietin levels are increased but the increase is
blunt in comparison to the anaemia.
Mechanisms of development of ACD are many but
the most important are erythropoiesis restriction as a
result of iron unavailability, abnormal iron
metabolism with trapping of iron in macrophages
and inadequate erythropoietic secretion as well as
resistance to erythropoietin. During inflammation,
release of iron from macrophages and liver stores is
inhibited. IL-6 which is released as a cytokine during
inflammation induces hepcidin production form
liver. The latter inhibits release of iron from
macrophages leading to hypoferremia. This
hypoferremia or functional iron deficiency (so called
starvation in midst of plenty) is the defining feature
of ACD.
It is very important to differentiate IDA from ACD.
Sometimes the two may co-exist for example in
rheumatoid arthritis. Table 1 summarizes the
laboratory investigations that differentiate ACD
from IDA. The laboratory diagnosis of ACD is made
by low serum iron, low transferrin saturation and
normal or increased ferritin level. This is in sharp
contrast to iron deficiency where serum ferritin is
low but transferrin receptors are increased. It is
important to note that bone marrow examination is
usually not required to discriminate iron deficiency
anaemia from ACD.

ACD

IDA

ACD + IDA

Iron

Reduced

Reduced

Reduced

Transferrin

Reduced to normal

Increased

Reduced

Transferrin saturation

Reduced

Reduced

Reduced

Ferritin

Normal to increased

Reduced

Reduced

Soluble transferrin
receptor

Normal

Increased

Normal to increased

Cytokine levels

Increased

Normal

Increased

Table1: Laboratory investigations to differentiate anaemia of chronic disease from iron deficiency anaemia (IDA)
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Haematogones: A Pitfall in the Diagnosis of
Leukemias/Lymphoma in Children
Drs Raihan Sajid, Bushra Moiz,
Assistant Professors, Haematology
Haematogones are benign lymphoid
precursors which appear morphologically
and immunophenotypically similar to
lymphoblasts in children. These cells
have been observed after cessation of
chemotherapy in acute lymphoblastic
leukemia (ALL), following bone marrow
transplantation, during infection, in
children with non haemopoietic
neoplasms and even in healthy children.
M o r p h o l o g i c a l l y, h a e m a t o g o n e s
resemble lymphoid cells varying in size
from 10 to 20 µ. They have round or oval
nuclei having one or more indentations or
shallow clefts and condensed
homogeneous chromatin (Figure 1 and 2).
Nucleoli are either absent or small and
indistinct. There is generally scanty or no
discernible cytoplasm which when
present is moderate to deeply basophilic
being devoid of granules, inclusions, or
vacuoles. There can be various other
cytologic features that make them blend
with mature lymphocytes.
One of the clinical settings in which
haematogones cause diagnostic
confusion, is following treatment for ALL
becaused hemtogones are frequently
increased in regenerating marrow and can
potentially be mistaken for residual
disease. Definitive diagnosis requires
evaluation of case by flow cytometry, as
haematogones can be distinguished from
ALL blasts because they tend to express
TdT strongly and CD10 and CD19
weakly whereas the reverse pattern of
reactivity is seen with ALL blast cells.
One of the important features which are
characteristic of haematogones is
expression of markers ranging from
maturity to immaturity - a fact that is
recognized as smearing on flowcytometry.
In sharp contrast, blasts usually express
immature markers.

Figure 1: Haematogones as seen in bone marrow aspirate of an Acute Lymphoblastic
Leukemia patient during remission phase.

Figure 2: Bone trephine from same patient showing haematogones (40X).
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Porphyria: The Mysterious Disease
Dr Lena Jafri,
Resident, Clinical Biochemistry

Porphyrins are a group of tetrapyrroles differing in
the composition of their side chains. They are
intermediate metabolites of haem synthetic pathway.
In humans there are three main porphryins, namely
uroporphyrin, coproporphrin and protoporphyrin.
Porphyrias are the disorders characterised by
deficiency of specific enzymes catalyzing
intermediary steps in haem synthetic pathway. As
shown in figure 1, various enzymes may be
affected giving rise to different forms of
porphyrias. As a result of enzyme blockade,
there is overproduction of haem intermediates,
which are potentially toxic and causes the
characteristic
neurovisceral
and
photosensitizing symptoms seen in different
types of porphyria (Table 1). Although the
mechanism is unclear, the porphyrias
associated with increased production of
delta-aminolevulinic acid (ALA) and/or
porphobilinogen (PBG) are associated with
neurovisceral complaints. Porphyrins cause
photosensitization and skin damage through
exposure to ultraviolet light (Figure 2), with
subsequent production of tissue-damaging
free radicals. Water soluble precursors are
excreted mainly in the urine (ALA, PBG, and
uroporphyrin), protoporphyrin is excreted
mainly in the faeces, and coproporphyrin is
excreted in both.

severe cases of AIP, the urine may develop a portwine color, due to a high concentration of
porphobilin, an autooxidation product of PBG.
Urinary porphyrins are increased in all three acute
porphyrias. Positive screening tests are followed by
quantitative measurement of total porphyrins in a 24
hours urine sample. Elevated porphyrin is then
identified.

Glycine

Succinyl CoA

ENZYMES

PORPHYRIAS

ALA synthase
ALA
ALA dehydratase

ALA dehydratase-deficiency porphyria
PBG
Acute intermittent porphyria

PBG deaminase
Uroporphyrinoge I
Uroporphyrinogen III synthase

Congenital erythropoietic porphyria [CEP]
Uroporphyrinoge III

Uroporphyrinogen Idecarboxylase

Porphyria actanea tarda
Coproporphyrinogen
Hereditary coproporphyria

Coproporphyrinogen oxidase
Protoporphyrinogen

Variegate porphyria

Protoporphyrinoge oxidase
Protoporphyrin

The role of biochemical investigations in
porphyrias is tremendous. Porphyria is
diagnosed through spectroscopy and
biochemical analysis of blood, urine, and stool.

Ferrochelatase

Figure 1: Haem synthesis pathway showing various types of Porphyrias

In Acute Intermittent Porphyria (AIP),
Hereditary Coproporphyria (HCP), or Variegate
Porphyria (VP) but not in ALA Dehydratase
Deficiency Porphyria (ALAD) increased excretion
of PBG is seen, with typical values being ten or more
times the upper limit of normal. Repeat testing
during an attack and subsequent attacks may be
necessary in order to detect a porphyria, as levels
may be normal or near-normal between attacks. In
7

Protoporphyria
Haem

Increased excretion of faecal porphyrins is seen in
VP and HCP. Fecal porphyrins consist of
coproporphyrin and protoporphyrin. Both
coproporphyrin and protoporphyrin are excreted in
huge amounts in VP and only coproporphyrin is
excreted in HCP.
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Red blood cell porphyrins are measured
as free erythrocyte protoporphyrin (FEP).
Normally it reflects concentration of Zn
protoporphyrin. These are greatly
increased in Congenital Erythropoietic
Porphyria (CEP) and protoporphyria but
are normal in other porphyrias. It may also
be increased in iron deficiency and lead
poisoning.
At AKUH Clinical Lab the following four
of the above mentioned tests for
diagnosing porphyria are available:
urinary ALA, urinary PBG, urinary
uroporphyrin and urinary coproporphyrin.

Figure 2: Skin of a patient suffering from Porphyria Cutanea Tarda showing typical
skin lesions.

Type

Deficient Enzyme

Classification

Congenital Erythropoietic
Porphyria (CEP)

Uroporphyrinogen III
cosynthetase

Erythropoietic

Erythropoietic
protoporphyria (EP)

Ferrochelatase

Erythropoietic

ALA dehydratase
deficiency porphyria (ALAD)

ALA dehydratase

Hepatic

Acute Intermittent
porphyria (AIP)

Porphobilinogen deaminase

Hepatic

Hereditary
coproporphyria (HCP)

Coproporphyrinogen oxidase

Hepatic

Variegate porphyria (VP)

Protoporphyrinogen oxidase

Hepatic

Porphyria cutanea tarda (PCT)

Uroporphyrinogen decarboxylase

Hepatic

Lead Poisoning

Ferrochelatase

Table 1: Various types of Porphyrias with their associated deficient enzymes
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Imaging Features of Thalassaemia and Sickle
Cell Anaemia
Drs Zishan Haider, Ishtiaq Chishti,
Farhan Ahmed, Dawar Khan,
Radiology
Thalassaemia and sickle cell anaemia are among the
common diseases which can give distinct imaging
features that point the diagnosis which are diagnostic.
Although the imaging features of Thalassaemia and other
chronic haemolytic anaemias are overlapping, it is
important to recognize the distinguishing features for
proper management in absence of adequate clinical clues.
Sickle cell disease is also among those diseases which
have a wide spectrum of manifestations including
avascular necrosis and osteomyelitis.
Thalassaemia
The radiographic features of thalassaemia result from
either a generalized marrow hypertrophy or hyperplasia, Figure 1: Skull X-ray showing hair-on-end appearance secondary to
expansion of diploic space with relative sparing of occipital region.
which may occur in other haemoglobinopathies, or a
reticuloendothelial storage process including Gaucher
disease. These may be diagnosed radiologically with a high degree of confidence, although additional clinical and
laboratory information may be required for the differential diagnosis of the haemoglobinopathies.
Skeletal response to marrow proliferation consists of expansion of the medulla, thinning of cortical bone, and
resorption of cancellous bone, which results in a generalised loss of bone density. Frequently, small areas of
lucency resulting from focal proliferation of marrow may be present,
often demarcated by coarsened but less numerous trabeculae. In addition,
the hypertrophic and hyperplastic marrow may perforate the cortex,
proliferate sub-periosteally, and stimulate a variety of periosteal
responses.
In weight-bearing bones, the resorptive process preserves the primary
trabeculae at the expense of secondary trabeculae. In the vertebral bodies,
a striated appearance resulting from thickened vertical trabeculae that
stands out against the paucity of horizontal trabeculae. In severely
affected patients, biconcavity of the superior and inferior margins of the
vertebral bodies or compression fractures may occur.
In the skull, widening of the diploic space (medulla) with a thinning of
the tables (cortices) occurs, frequently with complete obliteration of the
outer table. New bone forms in response to marrow proliferation beneath
the periosteum. These bony spicules may be seen radiographically and
result in a classic 'hair-on-end' appearance (Figure 1, 2).
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Figure 2: Axial CT scan of brain in bone window
showing expansion of diploic space due to
marrow expansion in skull.
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Proliferation of marrow within the frontal and facial bones impedes
pneumatisation of the paranasal sinuses. This results in hypertrophy of
osseous structures and a consequent prominence of the lateral margins of
the malar eminences, together with anterior and medial displacement of
developing teeth.
In the hand, the phalanges reveal the changes of cortical thinning,
expansion, osteopenia and coarsening of the trabeculae and may lose
their normal tubulation, which frequently results in a squared or sausageshaped configuration (Figure 3). A highly characteristic appearance
consists of bulbous expansion of the posterior, and to a lesser extent,
anterior segments of the ribs (Figure 4). Cardiomegaly may also be seen
secondary to anaemia.
In severe cases, soft tissue densities may be present in the posterior
mediastinum and, to a lesser degree, in the anterior mediastinum or
pelvis, known as extramedullary hematopoiesis (Figure 5). Apart from
these skeletal radiographic appearances, imaging can detect the presence
of haepatosplenomegaly, gall stones and haemosiderosis using the help
of ultrasound, CT scan or MRI.

Figure 3: X-ray hand showing decreased bone
density with expansion of metatarsals and
phalanges resulting sausage shape, secondary to
marrow expansion in thalassaemia.

Sickle Cell Anaemia (SCA)
Sickle Cell Anaemia is a haemolytic anaemia characterised by abnormally shaped (sickled) red blood cells (RBC),
which are removed from the circulation and destroyed at increased rates in spleen, leading to anaemia. These
sickled RBCs cause vascular occlusion, which in turn leads to tissue ischemia and infarction. For the vast majority
of patients the vaso-occlusive complications of the disease are much more clinically troublesome than is the
anaemia itself.
The skeletal changes of marrow hyperplasia are similar to
other haemolytic anaemias such as widening of diploic
space, biconcave vertebrae, coarsened ribs and trabeculae.
Endosteal apposition of bone is seen as inward cortical
thickening which is separated occasionally by a thin zone
of translucency, resulting typical appearance in the long
bones known as 'a bone within a bone'.
Skeletal complications include infarction and
osteomyelitis. Bone infarction is estimated to be much
more common than osteomyelitis, at least in children.
Infarction typically occurs in the medullary cavity and the
epiphysis, and it has been described in essentially every
marrow-containing bone. Bone marrow infarction is
thought to be the underlyingcause of most pain crises.
Infarction manifests first with an ill-defined zone of
radiolucency, which subsequently develops arc-like
subchondral and intramedullary luceney, with patchy
sclerotic areas. A peripheral rim of sclerosis is often seen,

Figure 4: Chest X-ray showing expanded anterior and posterior rib
expansion in thalassaemia.
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especially with medullary bone infarcts. Over time, these
areas will become sclerotic as fibrosis replaces the
infarcted region. The common sites of bone infarct are
femurs (Figure 6), humeral heads, vertebral bodies, hands
and feet. The radiographic appearance of femoral head
avascular necrosis is similar to Perthe's disease. In the
proximal humerus,
infarction gives rise to
area of diffuse sclerosis
known as 'snowcap sign'.
Central depressions in
endplates of vertebral
bodies on radiograph are
common and give rise to
Figure 5: Post contrast CT scan of chest in bone window showing
typical H-shaped vertebra,
coarse trabeculated expanded ribs with para-vertebral soft tissues
bilaterally along dorsal spine suggestive of extramedullary
may
be
seen
in
haematopoiesis.
asymptomatic patients.
Infarcts may be massive,
causing bone destruction, sequestration, reactive sclerosis and even the formation
of involucrum. When the metaphysis is involved significant deformity may occur
due to growth arrest. Central metaphyseal defects and lucencies are typical. These
in turn may produce fragmentation and deformity of the epiphyses. They may also
be the sites of pathological fractures. In sickle cell anaemia superadded infection is
very common and it is frequently challenging to differentiate it from infarcts even
with use of CT scan, MRI and nuclear scintigraphy.
Figure 6: MRI showing Coronal STIR
image of knee demonstrating
heterogeneous increased signals in
proximal femur suggestive of a bone
infarct.

N-Terminal ProBNP for Rapid Diagnosis of
Heart Failure
Ms Saba Azeem,
Technologist, Clinical Biochemistry
B-type natriuretic peptide (BNP) is a strong
diagnostic predictor of left-ventricular dysfunction.
Recently, the amino terminal portion of pro-BNP
(NT-proBNP) has been introduced in our clinical lab,
which is more sensitive because of its longer half-life.
BNP and NT-proBNP found in heart ventricles are
the two brain natriuretic peptides derived from the
prohormone, pro BNP (Figure 1). Unlike Atrial
Natriuretic Peptide whose major storage sites
11

include both atria and ventricles, the source of
plasma BNP is cardiac ventricle, where it is
synthesised as pre pro BNP and released as proBNP.
It is then enzymatically cleaved to NT-proBNP and
BNP upon stretching of ventricular myocyte. BNP
and NT-proBNP are released when the ventricle is
stretched due to hemodynamic pressure.
Both BNP and NT-proBNP are independent
predictors of high left ventricular end diastolic
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pressure and are useful for assessing mortality in
patients with chronic congestive heart failure. Their
levels increase progressively with increase in heart
failure. Use of BNP and NT-proBNP as population
screening tools for left ventricular systolic
dysfunction has been shown to be of value in
comparison with gold standard echocardiography.
BNP and NT-pro BNP assays are useful for screening
of heart disease, stratification of patients with heart
failure, detection of left ventricular dysfunction, and
differential diagnosis of dyspnea. They regulate
blood pressure and body fluid volume by their
natriuretic and diuretic actions, arterial dilation and
inhibition of rennin-angiotensin system.

Figure 1. The cardiac natriuretic peptide family. BNP, B-type
natriuretic peptide; NT, N-terminal; aa, amino acid.

BNP is cleared via specific natriuretic peptide
receptors as well as neutral endopeptidase in the
blood. In contrast NT-proBNP is assumed to be
cleared solely by renal excretion. Due to differences
in their molecular size and metabolism, there is a
variation between the utility of BNP and NT-proBNP
in diagnosis of congestive heart failure in patients
with chronic kidney disease. BNP has been approved
as a marker of CHF at a cut-off concentration of
100 pg/mL and NT-proBNP at a cut-off
concentration of 125 pg/ml. McCullough et al.
reported for the first time that the optimal cut-off for
BNP to diagnose CHF should be increased for
patients with an eGFR <60ml/min/1.73m2 (Table 1).
Therefore NT-proBNP values should be interpreted
with the clear understanding of renal function, body
mass index and age of the patient.

The diagnosis of heart failure in emergency
department is based on history and examination
together with chest X-ray and echocardiography.
The unreliability of history and examination findings
makes both treatment and decision making
challenging with potential for misdiagnosis and
increased morbidity. BNP or NT-pro BNP are
important new tests that can have a considerable
impact on the way we manage patients presenting to
the emergency with dyspnea and heart failure. It aids
in differentiating between cardiac and pulmonary
disease in patients with acute dyspnoea. It is a quick
and easy test for assessment of heart failure.
The test is performed by electrochemiluminescence
in AKUH Clinical Laboratory

Characteristic

BNP

NT-proBNP

Hormonally Active

Yes

No

Half life

20 minutes

1-2 hours

Clearance from body

Via specific natriuretic peptide
receptors as well as neutral
endopeptidase

Cleared solely by renal excretion

Effect of age on the levels

Increases with normal
aging +

Increases with normal aging ++++

Approved cutoff for congestive
heart failure diagnosis

100 pg/ml

Age <75 years 125 pg/ml
Age >75 years 450 pg/ml

Effect of kidney function on
the levels

Correlation with estimated
GFR = 0.20

Correlation with estimated
GFR = 0.60

Table 1: Comparison between BNP and NT-pro BNP.
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Frozen Section: A Rapid Diagnostic Tool
Dr Sabeen Mujtaba,
Resident, Histopathology
Frozen section is an imperfect but rapid method of
diagnosis while the patient is still in the operating
room. This is achieved through solidifying small
pieces of tissue in order to make thin sections
for histologic purpose. Similar to emergency
cases, the frozen section must solve the most
urgent problems for which the entire procedure
needs to be immensely fast.

Strict quality control measures are taken at AKUH
Clinical Laboratory for maintaining the quality of
reporting.

It is performed to provide rapid, gross or
microscopic diagnoses that can guide intra or
perioperative management of patient, to
confirm the presence and adequacy of tissue in
the lesion for a subsequent diagnosis on
permanent sections and to process tissue for
certain special studies for example enzyme
histochemistry, immuno histochemistry,
polymerase chain reaction, electron microscopy,
cytogenetics, hormone receptor analysis, etc.
On receiving the specimen, gross examination
is performed and Touch Preparations (TP) are
made and sections are placed on chucks.
Sections of the grossed specimen are made by
cryostat (Figure 1) and are submitted for H&E
stain. After staining (Figure 2), the slides are
reviewed by the histopathologist. The report is
communicated to the requesting surgeon by
phone immediately followed by the dispatch of
the report. Time required for this whole
procedure is approximately 25 minutes.

Figure 1: A technologist taking sections of tissue through microtome.

Some of the limitations of frozen section
include the following: only a small portion of
tissue can be frozen; ice crystal artifacts can be
produced; special studies cannot be performed;
further consultation cannot be taken as there is
limited time-frame.
It is important to make TPs for analysis due to
the following advantages. It is rapidly done and
easy to perform with lack of freezing artifacts.
In addition, large areas of tissue can be sampled
providing important cytological information
and avoiding contamination of cryostat with
infectious agent. It is also useful when tissue is
difficult to cut with cryostat, for example fat,
necrotic tissue and bone.
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Figure 2. Process of staining slide for microscopy.
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Prenatal Diagnosis of ß-Thalassaemia
Ms Toheed Kausar,
Senior Technologist, Molecular Pathology
Thalassaemia is the commonest single gene disorder
in Pakistan with a carrier rate of over 6%. Over 5,000
neonates are born every year with thalassaemia
major. The cost of treatment of thalassaemia is often
beyond the reach of an average Pakistani family. At
present the disorder can best be prevented through
prenatal diagnosis. A service for prenatal diagnosis

of ß- thalassaemia is registered for Chorionic Villous
Sampling (CVS) at Department of Radiology at 1015 weeks of gestation. At the same time, blood
samples are collected from each parent to perform
the mutations analysis. The CVS is dissected under a
stereo microscope. Maternal tissue, if any, is
carefully separated and only
placental villi are collected for
further DNA analysis.
The Amplification Refractory
Mutation System (ARMS) is used
to screen for ß- thalassaemia
mutations. In the first round, the
five most common ß thalassaemia
mutations are tested, followed by
a second or a third round for
uncommon or rare mutations,
when the mutation is not
identified. The five most common
mutations, IVSI-5(G-C), F.S 8/9
(+G), DEL 619 BP, FS 41-42 (TTCT) and IVSI-I (G-T)
constitute 82.3% of the total.
Maternal contaminations and
paternity is tested by VNTR
(Variable Number of Tandem
Repeats) analysis at various loci.

Figure 1: Gel strip showing prenatal diagnosis of ß- thalassemia.

of ß- thalassaemia was introduced in Pakistan in
1994 after consultation with two renowned Islamic
scholars. Accordingly, pregnancy can be terminated
if the foetus is affected by serious genetic disorder,
and if termination is before 120 days (17 weeks) of
gestations.
At AKUH, the couple requesting prenatal diagnosis

Prenatal
diagnosis
of
ß-thalassaemia has given a new
dimension to thalassaemia
prevention. It is technically
feasible and is particularly
accepted by families who have thalassaemic children.
In Pakistan there is a very strong tendency for a
person to marry within their ethnic group. Another
frequent custom is marriage between close relatives,
especially first cousins. The situation results in an
unusually high frequency of autosomal recessive
disorders. This signifies the importance of public
awareness of thalassaemia at grass root level.
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Farewell to Administrative
Director, Mr Sajid Khan
Dr Raihan Sajid,
Haematology

Mr Sajid Khan joined Aga Khan University on June 1st , 1986 as Manager of Clinical Laboratories.
He was a key member of a professional team comprising of faculty, managers and technologists in establishing
AKUH Clinical laboratories as one of the top most laboratories and reference centre at national and international
level.
Mr Sajid Khan retired from services as administrative director clinical laboratory on July 30th , 2009 and shall be
remembered as a true gentle man, team leader and efficient manager.
The attached photograph is of his farewell. From left to right:
1st row : Ms Shahida Qureshi, Dr Rumina Hasan, Mr Sajid Khan, Dr Mohammad Khurshid, Dr Naila Kayani,
Dr Farooq Ghani, Dr Imran Siddiqui, Mr Sohail Baloch.
2nd Row: Drs Tariq Moatter, Shahid Pervaiz, Bushra Moiz, Asim Beg, Erum Khan
3rd Row: Drs Aysha Habib Khan, Abrar Barakzai, Imran Siddiqui
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